Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA32222
Max Phase: Preclinical
Molecular Formula: C22H36Br2N4
Molecular Weight: 354.54
Molecule Type: Small molecule
Associated Items:
ID: ALA32222
Max Phase: Preclinical
Molecular Formula: C22H36Br2N4
Molecular Weight: 354.54
Molecule Type: Small molecule
Associated Items:
Synonyms (1): 1,12-Bis(4-Aminopyridinium)Dodecane Dibromide
Synonyms from Alternative Forms(1):
Canonical SMILES: Br.Br.N=c1ccn(CCCCCCCCCCCCn2ccc(=N)cc2)cc1
Standard InChI: InChI=1S/C22H34N4.2BrH/c23-21-11-17-25(18-12-21)15-9-7-5-3-1-2-4-6-8-10-16-26-19-13-22(24)14-20-26;;/h11-14,17-20,23-24H,1-10,15-16H2;2*1H
Standard InChI Key: QXKBSWAARYHOJE-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 354.54 | Molecular Weight (Monoisotopic): 354.2783 | AlogP: 4.85 | #Rotatable Bonds: 13 |
Polar Surface Area: 57.56 | Molecular Species: BASE | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 12.43 | CX LogP: 5.30 | CX LogD: -1.49 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.48 | Np Likeness Score: -0.22 |
1. Bailey DM, DeGrazia CG, Hoff SJ, Schulenberg PL, O'Connor JR, Paris DA, Slee AM.. (1984) Bispyridinamines: a new class of topical antimicrobial agents as inhibitors of dental plaque., 27 (11): [PMID:6492075] [10.1021/jm00377a014] |
2. Ng CK, Singhal V, Widmer F, Wright LC, Sorrell TC, Jolliffe KA.. (2007) Synthesis, antifungal and haemolytic activity of a series of bis(pyridinium)alkanes., 15 (10): [PMID:17383187] [10.1016/j.bmc.2007.03.018] |
Source(1):